Investigators in Egypt found that intralesional corticosteroid injections (ILS) combined with narrow-band ultraviolet B (NB-UVB) light therapy presented as a well-tolerated therapeutic option for vitiligo.

The investigative team, led by Moetaz El-Domyati, MD, Minia University, Al-Minya, noted that concentrations of 0.625 and 1.25 mg/ml of triamcinolone acetonide were the safest treatment options, with fewer side effects and complications.

Read the full article at